Nicotine may advance pancreatic cancer


PHILADELPHIA, Jul 30, 2009 (UPI via COMTEX) -- Exposure to nicotine via smoking
has been linked to a greater risk of aggressive pancreatic cancer, U.S.
researchers say.

The study, published in the journal Surgery, suggests pancreatic ductal
adenocarcinoma will more likely become metastatic when there is a history of
smoking because a variant of the protein osteopontin linked to cancer growth --
called OPNc -- may be promoted by nicotine.

The researchers found OPNc expression on 87 percent of the invasive cancer
lesions analyzed -- of which 73 percent were from smokers. The OPNc expression
also correlated with higher expression levels of osteopontin. Premalignant
lesions expressed no OPNc.

"This is the first time a relationship between nicotine and OPNc expression has
been identified," study leader Dr. Hwyda Arafat of the Jefferson Medical College
of Thomas Jefferson University in Philadelphia says in a statement. "These data
are very exciting because now we can evaluate OPNc as a prognostic and
diagnostic marker of invasive PDA lesions."

The exact role of OPNc in advancing pancreatic cancer, Arafat says, remains to
be defined, but it could provide a unique potential target to control pancreatic
cancer aggressiveness -- especially in people who smoke cigarettes.



URL: www.upi.com


Copyright 2009 by United Press International

Disclaimer: References or links to other sites from Wellness.com does not constitute recommendation or endorsement by Wellness.com. We bear no responsibility for the content of websites other than Wellness.com.
Community Comments
Be the first to comment.